The workup found a cone — what happens to your refractive plan
Clinical evidence researched September 2026 · Prices researched July 2026
Almost everything written about keratoconus answers a question you did not ask. You came for a refractive operation; a scan raised a cone or a suspicion of one; and the pages you can find are about how the condition is treated. This page answers the refractive question instead. The short form: every tissue-removing procedure comes off the table, the one refractive option that removes no tissue stays on it, and the gate between you and that option is not a price or a surgeon's opinion but a demonstration that your cornea is not changing — which is measured over six to twelve months, against a published EVO ICL itinerary of six to seven days. A refractive plan after a cone finding is a two-trip plan. Knowing that today is worth more than any other fact on this page.
If you are looking for treatment rather than correction, you are on the wrong page and we would rather say so than keep you. Cross-linking, ring segments and corneal grafts are the management of keratoconus. Our sister property eyesurgerychina.com covers keratoconus treatment in China. This page stays on the refractive side: what a cone finding does to a plan to correct your prescription, and what the sequence looks like from there.
Suspect and keratoconus are two different words and the gap between them is most of the anxiety
The sentence people are handed at the end of a workup is rarely the sentence they carry home. Keratoconus suspect, forme fruste, subclinical, abnormal topography and early keratoconus are not synonyms, they are points on a continuum from a shape that cannot be confidently called normal to a disease with clinical signs, and only the far end of that continuum is a diagnosis of anything.
A suspect cornea, in the sense the screening frameworks use, is one whose tomography carries a feature associated with early disease — an asymmetric pattern, a thinnest point displaced from where it should sit, an index outside a reference range — in an eye that corrects to normal vision, shows nothing at the slit lamp, and has no documented history of changing. Every clause in that description is doing work. The finding lives entirely in the measurement; the eye, considered as an eye, is unremarkable.
So what has actually been established about you is narrower than it feels. Not that you have a disease. Not that your vision is going to deteriorate. What has been established is that a confident prediction cannot be made about how this tissue would behave if part of it were removed — and a laser refractive procedure is, in its entirety, a bet on that prediction. The finding ends the bet. It does not diagnose you.
That is also why two surgeons can read the same map differently without either being wrong or dishonest. The indices are guides to a judgement about acceptable risk, not pass marks, and the person carrying the risk is the one being asked to sign for it.
What the finding does to each procedure, one row at a time
This is the table that does not exist elsewhere, because domestic keratoconus pages have no reason to organise the information by procedure and refractive clinic pages have no reason to publish the row that says no.
| Procedure | Removes corneal tissue? | Status on a suspect or keratoconic cornea |
|---|---|---|
| Femto-LASIK | Yes — flap plus stromal ablation | Off the table. A flap removes load-bearing tissue and cuts the anterior stroma; an abnormal preoperative topography is the most consistently named risk factor for post-operative ectasia in every screening framework in use. |
| SMILE | Yes — lenticule extraction | Off the table. Flap-free is not tissue-free: the correction is still made by removing a piece of stroma. The absence of a flap does not answer the mechanical question. |
| TransPRK | Yes — surface ablation | Off the table as a refractive procedure in its own right. Surface ablation is the usual reroute for a thin cornea, which is why people assume it is the reroute here too — but thinness and suspected instability are different problems and only the first of them is arithmetic. |
| EVO ICL | No — lens placed inside the eye | Not ruled out by the mechanism, and gated on documented stability. This is the row the rest of the page is about. |
| Spectacles / rigid or scleral lenses | No | Available throughout, including during the monitoring window. A rigid lens corrects by putting a smooth optical surface in front of an irregular cornea, which is something no spectacle lens can do. |
Procedure availability is a general statement about mechanism. Whether any of them is appropriate for your eyes is determined by the operating surgeon after the full diagnostic workup.
The clock this starts is measured in months, and your itinerary is measured in days
Here is the arithmetic that changes what a reader does today, and it is the reason this page exists rather than a reassurance that options remain.
The published route to refractive correction on a keratoconic or suspect cornea runs through an implanted lens, and the series that report it share a precondition that consumer material drops: the cornea had to be stable, and stable meant documented. A retrospective interventional series of 86 eyes in 64 patients found toric phakic lens implantation safe and effective for residual refractive error in keratoconus after stabilisation, and emphasised that outcomes turn on baseline refraction, corneal irregularity and disease stability. Earlier two-step work staged the lens after the stabilising procedure at an interval of about six months. Stability itself is established by repeating the tomography — the standard cadence runs at roughly three, six and twelve months — and refractive correction is generally not optimised until the cornea has held still across that window.
Now set that against what this site publishes about trips.
| What you were planning | Published duration | What a cone finding replaces it with |
|---|---|---|
| Femto-LASIK trip | ~4–5 days in country | Cancelled, not rescheduled |
| SMILE trip | ~4–5 days in country | Cancelled, not rescheduled |
| EVO ICL trip | 6–7 days in country | Deferred behind a stability demonstration of 6–12 months |
| Decision point | The day of the workup | The date of a repeat scan that has not been taken yet |
Itinerary lengths are this site's published ranges for uncomplicated cases. Monitoring intervals are the cadences named in the clinical literature, not a schedule anyone has set for you.
The ratio is roughly thirty to sixty. A reader arrives holding a plan denominated in days and leaves holding one denominated in months, and no page currently tells them that before they book the flights. That is the whole of the finding, and everything else here is detail hanging off it.
Two things follow that are actionable rather than merely true. First, the monitoring does not have to happen in China. Repeat corneal tomography is an ordinary test available in most countries, and a series of scans taken at home over the following year is by a wide margin the cheapest way to spend the window — it costs nothing in flights, nothing in leave, and it produces exactly the document any future plan requires. Second, the window cannot be compressed. There is no premium that buys a shorter one, because what is being waited for is not a queue but a measurement that has to be taken twice with time in between. A centre offering to shorten it is offering to skip it.
If the finding was made in China and you are standing in the building
The trip is not wasted, and it is worth being concrete about why rather than offering comfort. You have just received a tomographic screening and a specialist reading of it, which is the expensive and hard-to-obtain part of the process, and you now hold something you did not have this morning: a dated baseline scan. Every future assessment of whether your cornea is changing is a comparison against a first measurement, and you are now in possession of one.
So the useful thing to do with the remaining hours is documentary rather than clinical. Ask for the raw measurements and the maps themselves, in a form you can carry — not a verdict, and not a summary letter. Ask which instrument was used, because comparisons across different machines are weaker than comparisons on the same one, and the make and model on your baseline determines what a future scan should ideally be taken on. Ask what would have to be true for the answer to change, and on what interval they would want it re-measured. Those three questions convert a bad afternoon into the first entry in a file.
What does not follow is re-pointing the schedule at a substitute operation in the days you have left. The reason the laser was declined is the reason the week cannot simply be spent on something else, and a decision taken under the pressure of an expiring hotel booking is the worst-conditioned decision available to you.
Why this is found at a refractive workup more than anywhere else
There is a real asymmetry here that surprises people, and it is worth stating because it reframes the finding from bad luck into a predictable consequence of what you walked into.
A routine sight test establishes your correction and the health of your eye. It is not attempting to predict mechanical behaviour under tissue removal, and on a suspect cornea there is usually nothing for it to find — corrected vision is normal, the slit lamp is unremarkable, and the patient has no symptoms. The refractive workup is a different instrument answering a different question: it adds corneal tomography, which maps the posterior surface and the thickness distribution rather than only the front curvature, and Chinese refractive practice screens against national early-keratoconus guidance published by the refractive-surgery and corneal-disease groups precisely to underpin pre-operative evaluation.
So the refractive workup is, for most people who have one, the densest corneal screening of their lives — and it is administered to a self-selected population of myopes in their twenties and thirties, which is exactly the demographic in which early disease would be found if it were there. The workup is not disagreeing with your optometrist. It is answering a question your optometrist was never asked. A finding made this way is the screening working, which is an unsatisfying thing to be told and a true one.
What we will not tell you, and why
We publish no probability that your suspect finding will progress, because that number depends on which index flagged you, by how much, at what age, and on a comparison scan that does not exist yet — and a page that offered one would be inventing precision. We publish no partner-hospital rate of anything related to this, because we hold no such figure. We do not describe how keratoconus is treated, because treatment is not a refractive decision and it belongs to eyesurgerychina.com. And we do not tell you that a lens is definitely available to you, because that is a judgement made on the interior of your eye — anterior chamber depth, endothelial cell count, angle anatomy — by the surgeon who would perform it, on measurements taken after the stability question is settled.
Questions people actually ask
The workup in China said 'keratoconus suspect'. Does that mean I have keratoconus?
No, and the distinction is the most consequential thing on this page. 'Suspect' is a screening category, not a diagnosis. It describes a cornea whose tomography carries one or more features that appear in early disease — an asymmetric pattern, a displaced thinnest point, an index outside the reference range — while the eye itself has normal corrected vision, no slit-lamp signs and no documented change over time. A large proportion of eyes that carry that label never progress to anything. What the label does is describe a cornea about which a prediction cannot be made confidently, and a refractive procedure is entirely a bet on a prediction. So the label is not a statement that you are ill; it is a statement that nobody can yet promise how the tissue would behave if a surgeon removed part of it. That is why the same finding can end a laser plan and leave the rest of your eye health completely unremarkable. Whether a given map is a suspect finding, a normal variant or early disease is determined by the examining ophthalmologist on the day, not by a page.
Can I have LASIK or SMILE if the scan shows a keratoconus suspect pattern?
In essentially all circumstances, no, and this is one of the few places in refractive surgery where the profession is close to unanimous rather than split. LASIK, SMILE and TransPRK are all subtractive: each of them corrects your prescription by permanently removing corneal tissue, which is the same tissue that provides the cornea's mechanical strength. Removing material from a cornea already suspected of being mechanically weaker than normal is the specific mechanism behind post-operative ectasia, and an abnormal preoperative topography is the most consistently reported risk factor for it in every screening framework in use. The corollary matters as much as the rule: a surgeon who declines you on a suspect map has not been unusually cautious, they have applied the standard of care, and a surgeon who offers to proceed anyway is the one whose reasoning you should ask about in detail. Note that this is a statement about tissue-removing procedures specifically. It says nothing about whether any correction is possible, which is a separate question with a different answer.
Is EVO ICL an option if I have keratoconus or a suspect cornea?
It is the one refractive option that is not ruled out by the mechanism, and it is not available to you on the trip you had booked. Both halves of that sentence matter. An implantable collamer lens corrects the prescription with a lens placed inside the eye and removes no corneal tissue at all, so it does not weaken the structure that is already under suspicion — which is why the published literature on refractive correction in keratoconus is dominated by phakic lenses rather than by lasers. A retrospective interventional series of 86 eyes in 64 patients reported toric phakic lens implantation to be safe and effective for residual refractive error in keratoconus, and older two-step series staged the lens after stabilisation at an interval of about six months. But every one of those series shares a precondition that consumer pages leave out: the cornea had to be STABLE and documented as stable first, and in the suspect case that documentation does not exist yet because the suspicion is precisely that stability is unproven. So the honest answer is that a lens may well be your route, and it is a route that starts with a period of monitoring rather than with a booking. Suitability is determined by the operating surgeon after the full workup, and an irregular cornea also limits how well any spectacle-plane correction can perform, which is a separate conversation from whether the lens can be implanted.
How long before I could have any refractive procedure after a cone is found?
Plan in months and expect the answer to be given in scans rather than in dates. The gate is not a waiting period that elapses; it is a demonstration that the cornea is not changing, and that demonstration is made by repeating the tomography and comparing. The standard monitoring cadence after a cone-related finding or intervention runs at roughly three, six and twelve months, and refractive correction is generally not optimised until the cornea has held still across that window — six to twelve months is the interval the clinical literature repeatedly names, and the staged lens series used about six. Two practical consequences follow for a traveller. First, nobody can quote you a date on the day of the finding, because the date is contingent on measurements not yet taken. Second, the monitoring itself does not have to happen in China — repeat tomography is an ordinary test available in most countries, and a series of scans taken at home is the cheapest possible way to spend that window. What you cannot do is compress it, and a centre offering to is telling you something.
I have already booked flights. Should I still fly?
That depends on which finding you are holding, and the distinction is worth ten minutes before you decide. If a cone was raised at a workup you had at home and you have not yet travelled, the strong answer is to resolve it before flying rather than after — repeat tomography at home costs a fraction of a cancelled trip, and the finding will not resolve in transit. If the finding was made in China and you are already there, the trip is not wasted in the way it feels: you have obtained a tomographic screening and a specialist reading of it, which is the expensive part of the pre-operative process, and you now have a baseline scan with a date on it. That baseline is the first of the comparison series any future refractive plan will need, so ask for the raw measurements and the maps in a form you can carry, not merely a verdict. What does not follow is booking a substitute procedure in the remaining days. The reason the laser was declined is the reason the schedule cannot simply be re-pointed.
Why did a hospital in China find this when my optometrist at home did not?
Because the instrument and the question are different, and the refractive workup is the densest corneal screening most people will ever receive. A high-street sight test establishes what correction you need and whether your eye is healthy; it is not attempting to predict mechanical behaviour under tissue removal, and on a suspect cornea there is frequently nothing to find on a routine examination — corrected vision can be entirely normal. The refractive workup adds corneal tomography, which maps the back surface and the thickness distribution rather than only the front curvature, and Chinese refractive practice screens against national early-keratoconus guidance published by the refractive-surgery and corneal-disease groups specifically to underpin pre-operative evaluation. So the finding is not a disagreement with your optometrist. It is the answer to a question your optometrist was never asked. It is also the reason the screening exists: the small minority of maps that turn out to matter are found this way and almost no other.
Does a keratoconus suspect finding mean my vision will get worse?
Not on its own, and this is where the anxiety attached to the word runs well ahead of the evidence. A suspect label attaches to eyes with normal corrected vision and no documented change — that is part of what makes them suspect rather than diagnosed — and a substantial share of such eyes are stable for as long as they are followed. What the label does justify is being followed, because the one thing that distinguishes a normal variant from early disease is whether it moves, and that can only be established by measuring twice. The practical instruction is therefore unglamorous and genuinely useful: get repeat tomography on a schedule your ophthalmologist sets, keep the maps, and note that a stable series is itself a result rather than an absence of one. If a series does show progression, that is a clinical matter handled by corneal specialists and it is not a refractive-surgery decision; we route those questions to eyesurgerychina.com rather than answering them here.
What about cross-linking — should I have that in China while I am there?
That is a treatment decision about a corneal condition, and it is outside what this site covers. We publish on refractive surgery — LASIK, SMILE, TransPRK and EVO ICL — and cross-linking, intrastromal ring segments and corneal grafts are the management of keratoconus rather than the correction of a refractive error. Our sister property eyesurgerychina.com covers keratoconus treatment in China, and it is the right place for the question of whether, when and where any of those is appropriate. What can be said from the refractive side is the sequencing, because it is the part that changes travel plans: in the published two-step series the stabilising procedure comes first and the refractive lens comes afterwards at an interval, not alongside it. So even where both are eventually indicated, they are not one trip, and anyone presenting them as a single package deserves a direct question about the interval between them.
Is there any correction I can have in the meantime?
Usually yes, and it is the part of the conversation that gets least attention because it is not surgical. Spectacles continue to work for as long as the irregularity is mild enough for a sphero-cylindrical correction to address it. Where it is not, the standard answer is a rigid or scleral contact lens, which corrects by placing a smooth optical surface in front of an irregular cornea and can restore vision that no spectacle prescription reaches — that is a fitting question for a contact lens specialist rather than a surgeon. One warning specific to this site's readership, and it is the one most often missed: rigid and overnight orthokeratology lenses reshape the cornea, so wearing them distorts exactly the measurements any future refractive assessment depends on. If you are in a monitoring window, the wash-out period before each scan is not optional and it is longer than most people assume. Ask what it is for your lens type and build it into the scan schedule rather than discovering it on the day.